首頁
Accord Healthcare, Inc.

8月 2026Accord Healthcare, Inc.的市場佔有率分析

Accord Healthcare is a global provider of generic and specialty pharmaceuticals. Our focus on a rapidly expanding portfolio of affordable generic

健康 > 藥房

域名accordhealthcare.us

成立年份1976

僱員201 - 500

年度營收--

Accord Healthcare, Inc.

Accord Healthcare, Inc.（包含公司地區）

accordhealthcare.us

查看更多網站流量與參與度資訊

Accord Healthcare, Inc.的熱門網域總造訪量

了解Accord Healthcare, Inc.市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

accordhealthcare.us6.7K

透過銷售情報查看更多內容

Accord Healthcare, Inc.的熱門網域平均造訪時長

分析Accord Healthcare, Inc.參與度指標。

過去 3 個月平均造訪時長

子公司細目

accordhealthcare.us00:00:36

透過銷售情報查看更多內容

Accord Healthcare, Inc.的熱門網域平均頁面瀏覽量

了解Accord Healthcare, Inc.如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

accordhealthcare.us1.83

透過銷售情報查看更多內容

Accord Healthcare, Inc.按網域劃分的熱門競爭對手

看起來這裡的數據不足

無可顯示數據

使用的熱門技術Accord Healthcare, Inc.

这些是Accord Healthcare, Inc.顶级域名使用的行业网站技术

小工具 (6)

Twemoji

付費廣告 (2)

Google Adsense

內容管理系統 (2)

WordPress

行動裝置 (2)

Meta Viewport

更多技術

4

檢視所有

新聞與訊號來自Accord Healthcare, Inc.

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Accord Healthcare, Inc. launched Sugammadex Injection on Aug 5th '26.RALEIGH, N.C., Aug. 5, 2026 /PRNewswire/ - Accord Healthcare, Inc., a leading generic pharmaceutical company, committed to improving access to affordable medicines, today announced the launch of Sugammadex Injection, indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery.

新聞Accord Healthcare Inc launched Tadalafil Tablets on May 4th '26.RALEIGH, N.C., May 4, 2026 /PRNewswire/ - Accord Healthcare, Inc., a leading generic pharmaceutical company, committed to improving access to affordable medicines, today announced the relaunch of Tadalafil Tablets, an FDA-approved phosphodiesterase type 5 (PDE5) inhibitor for oral administration, available in multiple dosage strengths.

新聞Accord Healthcare Inc launched Lenalidomide Capsules on Feb 17th '26.RALEIGH, N.C., Feb. 17, 2026 /PRNewswire/ - Accord Healthcare, Inc., a leading U.S. pharmaceutical company, today announced the launch of Lenalidomide Capsules in the United States, reinforcing the company's commitment to expanding access to high-quality, affordable oncology therapies for patients.